Market News AIOpen the app

ORKA stock news · Oruka Therapeutics

Stories about Oruka Therapeutics (ORKA) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for ORKA

Follow Oruka Therapeutics (ORKA) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ORKA
Free on the App Store and Google Play, or on the web.
  1. Nov 9, 2026, 7:28 PM ET · Market

    Oruka Therapeutics lost $50 million last quarter and shared updates on its drug projects.

    Good for ORKA

    Oruka ended the third quarter with $1.2 billion in cash and reported a $50 million loss. Positive Phase 2 results make this update favorable, despite higher costs.

  2. Oct 21, 2026, 9:38 AM ET · Market

    An insider at Oruka Therapeutics sold $706,735 worth of company shares.

    Neutral

    Oruka insider Paul T. Quinlan sold $706,735 in company shares.